<DOC>
	<DOC>NCT00480662</DOC>
	<brief_summary>To test the safety, effectiveness of MK0217 when taken once a week for six months in treating patients with Paget's bone disease.</brief_summary>
	<brief_title>A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteitis Deformans</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Male or female, ages 18 to 90 years with a diagnosis of Paget's bone disease Patient cannot stand or sit upright for at least 30 minutes Patient has difficulty swallowing or problems with digestive system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Paget's bone disease</keyword>
</DOC>